Introduction {#s1}
============

Quality control during translation of the genetic code involves multiple stages and a multitude of proofreading factors ([@bib19]; [@bib23]; [@bib31]; [@bib37]). A compromise in editing leads to serious pathologies including neurodegeneration in mouse, and even cell death ([@bib3]; [@bib8]; [@bib24]; [@bib26]; [@bib30]; [@bib32]; [@bib33]; [@bib35]; [@bib36]; [@bib43]). Among these proofreading factors, D-aminoacyl-tRNA deacylase (DTD) is the one that specifically decouples wrongly acylated D-amino acids from tRNAs ([@bib10]; [@bib49]; [@bib48]). Our studies have shown that DTD is an RNA-based catalyst that uses an invariant Gly-*cis*Pro motif as a 'chiral selectivity filter' to achieve substrate chiral specificity only through rejection of L-amino acid from the active site, thereby leading to Gly-tRNA^Gly^ misediting ([@bib2]; [@bib41]; [@bib42]). Recently, we have also shown that DTD's activity on achiral glycine helps in clearing Gly-tRNA^Ala^, a misaminoacylation product of alanyl-tRNA synthetase (AlaRS), thus resolving a long-standing question in translational quality control ([@bib38]).

As DTD acts on multiple tRNAs charged with D-amino acids or glycine, tRNA's role in modulating DTD's activity was previously thought to be inconsequential ([@bib10]). However, our recent work has shown that DTD's activity on Gly-tRNA^Ala^ is about 1000-fold higher than on Gly-tRNA^Gly^, clearly demonstrating the profound effect of tRNA elements on DTD and suggesting an underlying tRNA code for DTD's action. G3•U70, the universal tRNA^Ala^-specific determinant for AlaRS, is also a determinant for DTD. However, it enhances DTD's activity by only about 10-fold ([@bib38]), leaving the 100-fold difference in activity unaccounted for. Here, using exhaustive tRNA sequence analysis and biochemical studies, we identify tRNA's discriminator base (N73) as the major modulator of DTD's activity (unless stated otherwise, DTD refers to bacterial DTD). The invariant uracil (U73) in bacterial Gly-tRNA^Gly^ serves as an anti-determinant and enables the substrate's escape from misediting by DTD, thereby preventing cognate depletion. Using a reporter assay based on green fluorescent protein (GFP), we further demonstrate that DTD is not merely a recycler of Gly-tRNA^Ala^ but avoids glycine misincorporation in proteins. Thus, the study has deciphered the tRNA elements that modulate DTD's activity to ensure faithful delivery of glycine to the ribosomal apparatus during protein biosynthesis. The current work has elucidated why bacterial tRNA^Gly^s---both proteinogenic and non-proteinogenic---have U73 and deviated from harboring purine as N73 during evolution, suggesting for the first time the role of proofreading factors such as DTD in shaping the discriminator base code of tRNAs. The study provides an explanation for a key anomaly in the elegant 'Discriminator Hypothesis' originally proposed by Donald Crothers nearly half a century ago ([@bib12]).

Results {#s2}
=======

U73 is an idiosyncratic feature of bacterial tRNA^Gly^ {#s2-1}
------------------------------------------------------

To identify tRNA elements other than G3•U70 that play a role in modulating DTD's activity, we performed a thorough bioinformatic analysis of all the available 2,671,763 tRNA sequences, which were retrieved from tRNADB-CE ([@bib1]). Since DTD is known to act even on D-Tyr-tRNA^Tyr^ digested with T~1~ RNase ([@bib10]), it is not expected to interact beyond tRNA's acceptor stem. Therefore, we focused only on the conservation/variation of acceptor stem bases. The obvious difference is the invariable and unique G3•U70 in tRNA^Ala^, while the rest of the acceptor stem paired bases have no striking partitioning between tRNA^Ala^ and tRNA^Gly^, except the second base pair ([Figure 1b](#fig1){ref-type="fig"}). However, this is not likely to affect DTD's activity because the second base pair position is not conserved among different tRNAs (e.g., tRNA^Phe/Tyr/Trp/Asp^) on which DTD is known to act with similar efficiency ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) ([@bib10]; [@bib49]; [@bib48]). Surprisingly, bacterial tRNA^Gly^, tRNA^His^ and tRNA^Cys^ have a pyrimidine as N73, while the rest of the tRNAs including tRNA^Ala^ have a purine at that position ([Figure 1a,c](#fig1){ref-type="fig"}; [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}; [Table 1](#table1){ref-type="table"}). This indicated that N73 could have a role in the differential activity of DTD on Gly-tRNA^Gly^ and Gly-tRNA^Ala^.

![tRNA^Gly^ and tRNA^Ala^ show discriminator base dichotomy in Bacteria.\
(**a**) Clover leaf model of tRNA with the discriminator base highlighted in red. (**b**) Frequency distribution of tRNA acceptor stem elements across bacterial tRNAs, comparing and contrasting between tRNA^Gly^ and tRNA^Ala^. Red circle indicates the discriminator base. (**c**) Distribution of the discriminator base in all tRNAs across the three domains of life. The instances where the discriminator base shows \>90% conservation has been represented by the most frequent base. In the case of tRNA^Thr^, U73 and A73 together represent \>90% frequency of occurrence; A/U in Bacteria implies A73 is more abundant than U73, whereas U/A in Eukarya denotes U73 is more abundant than A73. Amino acids are color-coded on the basis of the class to which the corresponding synthetases belong: yellow, class I; blue, class II; orange, both class I and II. Discriminator base color-coded as follows: green, purine (A or G); red, pyrimidine (U or C); grey, purine and pyrimidine (A/U or U/A).](elife-38232-fig1){#fig1}
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###### Table showing the number of tRNAs having a particular discriminator base for all tRNAs across bacteria.

  **tRNA^X^**   **A73**   **G73**                  **C73**     **U73**   **Total**
  ------------- --------- ------------------------ ----------- --------- -----------
  **Ala**       136822    9                        6           9         136846
  **Ile**       61982     28                       3           3         62016
  **Leu**       259624    13                       9           5         259651
  **Lys**       123064    122                      40          510       123736
  **Met**       207181    12                       253         1868      209314
  **Phe**       68315     20                       2           4         68341
  **Pro**       110670    9                        1           3         110683
  **Tyr**       80595     5                        6           50        80656
  **Val**       187250    10                       7           3         187270
  **Arg**       119819    103052                   32          10151     233054
  **Glu**       29469     54764                    8           46        84287
  **Asn**       20        129816                   6           41        129883
  **Asp**       17        121556                   1           3         121577
  **Gln**       787       102405                   6           2250      105448
  **Ser**       1336      192697                   6           3119      197158
  **Trp**       5         54387                    0           23        54415
  **Thr**       131288    34                       95          28854     160271
  **Cys**       5         2                        8           56956     56971
  **Gly**       239       11                       4           231855    232109
  **His**       2004      4                        56052       17        58077
                          Total bacterial tRNAs:   2,671,763             

Pyrimidine as N73 acts as an anti-determinant for DTD {#s2-2}
-----------------------------------------------------

To test the role of N73 in modulating DTD's activity, we generated U73A, U73G and U73C mutants of tRNA^Gly^ from *Escherichia coli*. Strikingly, biochemical assays showed that DTD from *E. coli* (EcDTD) deacylates Gly-tRNA^Gly^(U73A) or Gly-tRNA^Gly^(U73G) at 0.1 nM, whereas it shows similar activity on Gly-tRNA^Gly^ at 10 nM ([Figure 2a,c,d](#fig2){ref-type="fig"}). Thus, EcDTD has nearly 100-fold higher activity on Gly-tRNA^Gly^(U73A) or Gly-tRNA^Gly^(U73G) compared to its activity on the wild-type substrate. In the case of Gly-tRNA^Gly^(U73C), EcDTD's activity at 10 nM is similar to that on Gly-tRNA^Gly^ at the same concentration, thus displaying comparable efficiencies for both substrates ([Figure 2a,b](#fig2){ref-type="fig"}). This clearly demonstrates that N73 is a key element on tRNA that dictates the efficiency of DTD, and purine as N73 is the preferred base for the enzyme. Our data is further strengthened by the fact that all the reported substrates of DTD, namely D-Tyr-tRNA^Tyr^, D-Phe-tRNA^Phe^, D-Trp-tRNA^Trp^ and D-Asp-tRNA^Asp^, have purine as N73 ([Figure 1c](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) ([@bib10]; [@bib49]; [@bib48]). This also shows that N73 has a stronger influence on DTD than G3•U70 (which creates only about 10-fold difference) and it can majorly account for the observed 1000-fold difference in DTD's activity on Gly-tRNA^Gly^ and Gly-tRNA^Ala^ ([@bib38]). This further prompted us to test the combined effect of N73 and G3•U70 on DTD's activity.

![Discriminator base modulates DTD's activity.\
(**a--e**) Deacylation of Gly-tRNA^Gly^ and its mutants by various concentrations of EcDTD. (**f**) Deacylation of Gly-tRNA^Ala^ by various concentrations of EcDTD. Lines indicate exponential decay fits and error bars represent one standard deviation from the mean of at least three independent readings.\
10.7554/eLife.38232.007Figure 2---source data 1.Biochemical data for EcDTD deacylations with Gly-tRNA^Gly/Ala^ (wild type and mutants).](elife-38232-fig2){#fig2}

N73 and G3•U70 have an additive effect on DTD's activity {#s2-3}
--------------------------------------------------------

To ascertain whether N73 and G3•U70 are mutually independent such that they can have a cumulative effect on DTD's activity, we generated U73A/C70U double mutant of tRNA^Gly^. Biochemical assays showed that EcDTD's activity on Gly-tRNA^Gly^(U73A/C70U) at 0.01 nM is comparable to that on Gly-tRNA^Ala^, and is nearly 1000-fold higher than its activity on wild-type Gly-tRNA^Gly^ ([Figure 2a,e,f](#fig2){ref-type="fig"}). This unambiguously proves the additive effect of N73 and G3•U70 in modulating bacterial DTD's activity, wherein N73 plays the major role. More importantly, it shows that just two point mutations in the acceptor stem are necessary and sufficient to completely switch the specificity of tRNA^Gly^ to tRNA^Ala^, one which is an anti-determinant in tRNA^Gly^ and the other a positive determinant in tRNA^Ala^. These results also clearly establish that functionally important interactions of DTD are confined only to the acceptor stem of tRNA.

U73 is the key factor that prevents Gly-tRNA^Gly^ misediting by DTD {#s2-4}
-------------------------------------------------------------------

Our previous work had shown that elongation factor thermo unstable (EF-Tu) confers protection on Gly-tRNA^Gly^ from DTD's unwarranted activity ([@bib41]). tRNA elements on TΨC arm are known to be responsible for EF-Tu binding ([@bib28]; [@bib44]; [@bib47]). Hence, N73 mutation in tRNA^Gly^ is not expected to alter the binding affinity of Gly-tRNA^Gly^ to EF-Tu. Moreover, since the effect of U73 as anti-determinant of DTD seen here appeared stronger than the protective effect of EF-Tu observed earlier ([@bib41]), we hypothesized that N73 plays the dominant role in preventing misediting of Gly-tRNA^Gly^ by DTD. We probed this by performing competition experiments between EF-Tu and EcDTD. In the absence of EF-Tu, EcDTD acts on Gly-tRNA^Gly^ at 10 nM, while the presence of EF-Tu protects Gly-tRNA^Gly^ from 10 nM EcDTD. The substrate is, however, completely deacylated by 100 nM EcDTD even in the presence of EF-Tu. Thus, the protection offered by EF-Tu to Gly-tRNA^Gly^ against EcDTD is less than 10-fold ([Figure 3a](#fig3){ref-type="fig"}), which is in agreement with our previous study ([@bib41]).

![Discriminator base predominantly determines the fate of the substrate.\
Deacylation of (**a**) Gly-tRNA^Gly^ and (**b**) Gly-tRNA^Gly^(U73A) by EcDTD in the presence or absence of EF-Tu (\* indicates the data points are connected through line). Deacylation of (**c**) Gly-(Mm)tRNA^Gly^ and (**d**) Gly-(Mm)tRNA^Ala^ by various concentrations of MmDTD. Deacylation of (**e**) Gly-tRNA^Gly^ and (**f**) Gly-tRNA^Gly^(U73A) by various concentrations of MmDTD. Lines indicate exponential decay fit and error bars represent one standard deviation from the mean of at least three independent readings.\
10.7554/eLife.38232.010Figure 3---source data 1.Biochemical data for EF-Tu protection assays and MmDTD deacylations.](elife-38232-fig3){#fig3}

In the case of Gly-tRNA^Gly^(U73A), EcDTD's activity without EF-Tu is at 0.1 nM, while in the presence of EF-Tu, similar activity is observed at 1 nM ([Figure 3b](#fig3){ref-type="fig"}). Hence, irrespective of the identity of N73, EF-Tu offers only about 10-fold protection. Furthermore, the 100-fold difference in the activity of EcDTD on Gly-tRNA^Gly^(U73A) and wild-type Gly-tRNA^Gly^ is maintained even in the presence of EF-Tu. These findings clearly demonstrate that EF-Tu has no preference for N73, and it is DTD's differential activity that predominantly determines the fate of the substrate. Thus, EF-Tu augments the protection of Gly-tRNA^Gly^ primarily/majorly conferred by U73, that is the enhancement in protection of Gly-tRNA^Gly^ by EF-Tu is consequential only if the substrate harbors U73. Nevertheless, cellular DTD levels must be tightly regulated because DTD overexpression has been shown to cause toxicity ([@bib41]). While the above data indicated the role of DTD in depleting the cognate Gly-tRNA^Gly^ pool, it did not provide direct evidence to that effect. We therefore performed northern blotting analysis by overexpressing the wild-type and a catalytically inactive mutant of DTD (A112F) ([@bib2]), and monitoring the aminoacylated and free tRNA^Gly^ levels. In case of mutant DTD overexpression, the aminoacylated fraction is about 80% of the total tRNA^Gly^ pool which is similar to empty vector control. By contrast, overexpression of wild-type DTD causes complete depletion of Gly-tRNA^Gly^. Interestingly, cognate depletion is observed even in the uninduced sample of wild-type DTD, suggesting leaky expression of the wild-type copy from the recombinant plasmid ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). These data are suggestive that the toxicity caused by DTD overexpression is linked to the depletion of cellular Gly-tRNA^Gly^ levels.

G3•U70 is a universal determinant for DTD {#s2-5}
-----------------------------------------

Intriguingly, our bioinformatic analysis also revealed that the dichotomy of N73 seen in bacterial tRNA^Gly^ and tRNA^Ala^ is lacking in Archaea and Eukarya, that is both tRNA^Gly^ and tRNA^Ala^ in Archaea and Eukarya harbor A73 ([Figure 1c](#fig1){ref-type="fig"}). Thus, we envisaged that the difference in eukaryotic DTD's activity on eukaryotic Gly-tRNA^Gly^ and Gly-tRNA^Ala^ will be only about 10-fold due to G3•U70 in tRNA^Ala^ (notably, Archaea lacks canonical DTD and hence the problem of discrimination does not arise at all). To investigate this paradigm, we used DTD and tRNAs from *Mus musculus* (MmDTD and (Mm)tRNA^Gly/Ala^). Biochemical assays revealed that MmDTD acts on Gly-(Mm)tRNA^Gly^ and Gly-(Mm)tRNA^Ala^ at 100 nM and 10 nM, respectively ([Figure 3c,d](#fig3){ref-type="fig"}). These results clearly show that G3•U70 recognition by DTD is conserved even in Eukarya, contributing about 10-fold discrimination between eukaryotic tRNA^Gly^ and tRNA^Ala^. They also demonstrate that G3•U70 is the only available tRNA element that enables distinction between eukaryotic tRNA^Gly^ and tRNA^Ala^ by eukaryotic DTD. These findings further suggest that other mechanisms are possibly operating in eukaryotes to enhance the discrimination between Gly-tRNA^Gly^ and Gly-tRNA^Ala^, as discussed later.

Eukaryotic DTD has inverted N73 specificity {#s2-6}
-------------------------------------------

The lack of N73 difference in eukaryotic tRNA^Gly^ and tRNA^Ala^ further prompted us to investigate whether eukaryotic DTD has lost the specificity for N73. To probe the N73 effect on eukaryotic DTD, we performed biochemical assays using MmDTD and Gly-(Ec)tRNA^Gly^. MmDTD acts on U73-containing wild-type Gly-(Ec)tRNA^Gly^ at a concentration of 0.1 nM while it acts on Gly-(Ec)tRNA^Gly^(U73A) mutant with comparable efficiency at a concentration of 10 nM, thus displaying a 100-fold reduction in activity compared to the wild-type substrate ([Figure 3e,f](#fig3){ref-type="fig"}). The data indicate that N73 does affect eukaryotic DTD but the specificity/preference has switched from purine to pyrimidine. Therefore, eukaryotic DTD is equally modulated by N73 like its bacterial counterpart, but has inverted N73 specificity, that is bacterial DTD prefers purine while eukaryotic DTD prefers pyrimidine as N73; this provides a rationale as to why a mild overexpression of eukaryotic DTD from *Plasmodium falciparum* (PfDTD; eukaryotic DTD) creates more cellular toxicity when compared to that of EcDTD ([@bib41]). These findings clearly establish that eukaryotic DTD has also co-evolved with N73 like bacterial DTD, thereby helping to relieve the selection pressure of keeping U/C73 in eukaryotic tRNA^Gly^, as further explained later. Nevertheless, since none of the U/C73-containing eukaryotic tRNAs ([Figure 1c](#fig1){ref-type="fig"}) is known to be mischarged with glycine or corresponding D-amino acids, the physiological consequence of this switch in N73 specificity remains to be elucidated.

DTD prevents glycine misincorporation in proteins *in vivo* {#s2-7}
-----------------------------------------------------------

One of the major questions that came out of our recent work ([@bib38]) was whether DTD is just a 'recycler' of mischarged tRNAs, as has been shown in the case of D-aminoacyl-tRNAs ([@bib50]). D-aminoacyl-tRNAs are discriminated against by other cellular 'chiral checkpoints', namely EF-Tu and ribosome ([@bib6]; [@bib16]; [@bib39]; [@bib56]), which together with DTD preclude D-amino acid infiltration into the translational machinery. Since Gly-tRNA^Ala^ is not expected to be adequately distinguished from L-Ala-tRNA^Ala^ by EF-Tu and ribosome ([@bib14]), we hypothesized that glycine mischarged on tRNA^Ala^ can be misincorporated into the growing polypeptide chain in the absence of DTD, and that DTD's efficient activity on Gly-tRNA^Ala^ due to the presence of A73 and G3•U70 prevents this deleterious outcome. To test this hypothesis *in vivo*, we developed a GFP-based reporter assay ([Figure 4a](#fig4){ref-type="fig"}). The ability of GFP to fluoresce depends on a key motif (^65^S/TYG^67^) in which mutation of the invariant glycine to any other residue abrogates chromophore formation, resulting in complete loss of fluorescence ([@bib52]; [@bib58]). We expressed the non-fluorescing G67A mutant of GFP in an *E. coli* strain with/without DTD in the editing-defective AlaRS background ([@bib38]). While no GFP fluorescence is observed in cells with the genomic copy of *dtd* gene ([Figure 4b](#fig4){ref-type="fig"}), the *dtd* knockout strain shows GFP fluorescence upon glycine supplementation, clearly indicating misincorporation of glycine in place of alanine ([Figure 4c](#fig4){ref-type="fig"}). Moreover, the increase in fluorescence with increasing glycine supplementation in the *dtd*-null *E. coli* strain substantiates the increased toxicity upon glycine supplementation observed in our recent study ([@bib38]). These data clearly reveal that DTD is not merely a 'recycler' of Gly-tRNA^Ala^, but prevents alanine-to-glycine misincorporation in proteins and consequent cellular toxicity because A73 and G3•U70 in the substrate enable efficient editing by the enzyme.

![DTD avoids glycine misincorporation into proteins.\
(**a**) GFP-based fluorescence reporter assay for visualizing alanine-to-glycine mistranslation, wherein the mutant GFP G67A (^65^TYA^67^) will fluoresce only when TYA is mistranslated to TYG. Microscopy images showing GFP fluorescence in *E. coli* at different concentrations of glycine supplementation (**b**) in the presence and (**c**) in the absence of DTD. The *E. coli* strain used is MG1655 with editing-defective AlaRS gene (i.e. Δ*alaS*) ([@bib38]). (**d**) Model showing N73 dichotomy in bacterial tRNA^Gly^ and tRNA^Ala^, enabling protection of the cognate Gly-tRNA^Gly^ (both proteinogenic and non-proteinogenic) predominantly by U73, while effecting efficient removal of the non-cognate Gly-tRNA^Ala^ (having A73 and G3•U70) to prevent alanine-to-glycine mistranslation.](elife-38232-fig4){#fig4}

Discussion {#s3}
==========

The present work has identified N73 as the major factor that modulates DTD's activity. The invariant U73, which acts as an anti-determinant, is predominantly responsible for ensuring the escape of Gly-tRNA^Gly^ from DTD's unwarranted activity. Strikingly, this protection is essential and significantly higher than that offered by EF-Tu. Notably, EF-Tu's role in conferring protection on Gly-tRNA^Gly^ holds significance only when the substrate contains U73. Such a strong influence of U73 assumes even more importance for non-proteinogenic Gly-tRNA^Gly^, which are required for non-canonical functions (e.g., cell wall synthesis in Gram-positive bacteria) but are not known to interact with EF-Tu or any other protein, except the enzymes (like FemXAB) that utilize it ([@bib17]; [@bib25]). For this achiral species, U73 is the only means of preventing misediting by DTD and consequent cognate depletion. Interestingly, we have now shown that just two tRNA elements---N73 and G3•U70---are sufficient to completely switch DTD's tRNA specificity, thus accounting for the enzyme's 1000-fold difference in activity on Gly-tRNA^Gly^ and Gly-tRNA^Ala^. G3•U70 wobble base pair in the acceptor stem of tRNA^Ala^ is a universal determinant for AlaRS specificity ([@bib5]; [@bib21]; [@bib34]). This specificity is so strict that G•U at the third base pair position, or in certain cases even at the fourth base pair level, can result in AlaRS charging non-cognate tRNAs with L-alanine ([@bib27]; [@bib51]). We have further shown that G3•U70-based discrimination between tRNA^Gly^ and tRNA^Ala^ by DTD is also conserved in Eukarya. These findings unequivocally demonstrate the obligatory requirement for DTD to use tRNA elements in a major way to discriminate between two cellular substrates, one essential for protein synthesis and the other a misaminoacylated species, carrying the same amino acid, that is achiral glycine. Moreover, the study has also suggested that the high efficiency of bacterial DTD in clearing Gly-tRNA^Ala^ is the plausible reason why it shows significant activity on Gly-tRNA^Gly^, albeit at a 1000-fold less efficiency. This points towards an interesting trade-off between speed and accuracy that exists in the case of DTD's proofreading activity, thereby making DTD uniquely distinct from all other known editing enzymes. It further conforms to the notion that DTD levels in the cell must be tightly regulated.

Surprisingly, our *in silico* analysis has revealed that eukaryotic tRNA^Gly^ and tRNA^Ala^ both contain A73. The lack of N73 difference indicates that G3•U70 is the only discriminatory factor for eukaryotic DTD. It also suggests that in eukaryotes other mechanisms such as spatiotemporal regulation of expression and cellular compartmentalization of DTD may play role in preventing cognate (Gly-tRNA^Gly^) depletion. It is worth mentioning in this context that human DTD has been shown to be enriched in the nuclear envelope region ([@bib57]). Intriguingly enough, our data have revealed that eukaryotic DTD shows a switch in N73 specificity, that is unlike bacterial DTD, the eukaryotic enzyme prefers pyrimidine. However, the physiological relevance of this specificity switch in eukaryotic DTD remains to be elucidated. Moreover, whether such a tRNA-based discriminatory code exists for other standalone proofreading modules such as AlaXs, YbaK and ProXp-ala remains to be probed. Interestingly, such an acceptor stem based tRNA determinants has been shown to exist for other standalone proofreading modules also such as AlaXs, YbaK and ProXp-ala ([@bib4]; [@bib5]; [@bib15]; [@bib53]). These findings also suggest that bacterial DTD and A/G73-containing tRNA^Gly^ or eukaryotic DTD and U/C73-containing tRNA^Gly^ are likely to be incompatible. This can be seen from the delicate balance of the cellular concentrations of DTD and the deleterious effect of its overexpression in *E. coli* ([@bib41]).

The uneven, yet interesting, distribution of tRNAs into different discriminator classes based on N73 was used to propose an elegant 'Discriminator Hypothesis' by Donald Crothers about 50 years ago ([@bib12]). This classification also reflects the partitioning of tRNAs based on the chemical nature of the amino acid to be attached, that is A73 class includes tRNAs which code for hydrophobic amino acids, while G73-containing tRNAs code for hydrophilic amino acids ([@bib12]). As can be seen from our current bioinformatic analysis on the discriminator code usage from all three branches of life ([Figure 1c](#fig1){ref-type="fig"}), N73 is predominantly a purine. It has been already noted that factors like RNase P and CCA-adding enzyme have led to purine bias in N73 in all the three domains of life ([Figure 1c](#fig1){ref-type="fig"}) ([@bib9]; [@bib11]; [@bib18]; [@bib20]; [@bib22]; [@bib40]; [@bib55]). In the case of bacteria, the only variations to the purine-based discriminator code are tRNA^Gly/His/Cys^. C73 in prokaryotic tRNA^His^ is essential to retain G~-1~ during processing by RNaseP, while in the case of eukaryotic tRNA^His^, G~-1~ is added latter as a post-transcriptional modification ([@bib9]; [@bib11]). In tRNA^Cys^, U73 is essential for aminoacylation by cysteinyl-tRNA synthetase ([@bib20]). Recent evidence shows that CCA-adding enzyme prefers purine as N73 because pyrimidine at that position leads to slow addition of CCA as well as a compromise in the fidelity of CCA addition ([@bib55]). The above examples in conjunction with the current day discriminator code usage ([Figure 1c](#fig1){ref-type="fig"}) clearly demonstrate that a stronger selection pressure is required to deviate from a purine-based discriminator code. Therefore, it was striking that the tRNA coding for an amino acid which is achiral, having no side chain and of primordial origin is the only bacterial tRNA containing U73 which remained a major anomaly to the discriminator code. The current study has elucidated this hitherto unexplained case of bacterial tRNA^Gly^, wherein the evolutionary selection pressure exerted by DTD for retention of U73 appears stronger than that exerted by any of the other aforesaid factors. It also suggests that eukaryotes have evolved mechanisms that helped in relieving the selection pressure of keeping U73 in tRNA^Gly^, and eukaryotic DTD has co-evolved to switch its N73 specificity accordingly.

Taken together, the present work has added a new dimension to DTD's substrate selectivity, highlighting the role of two key tRNA elements, namely N73 and the G3•U70 wobble base pair. In this respect, it would be interesting to probe the mechanistic underpinnings for DTD's recognition mode using both bacterial and eukaryotic systems to help us understand the underlying cause of switch in N73 specificity. Furthermore, the current study has underscored the physiological importance of N73 dichotomy in tRNA^Gly^ and tRNA^Ala^ that maintains 'glycine fidelity' during translation of the genetic code in Bacteria by preventing misediting of Gly-tRNA^Gly^ as well as misincorporation of glycine in proteins ([Figure 4d](#fig4){ref-type="fig"}). In the latter context, therefore, DTD is not just a recycler of Gly-tRNA^Ala^, unlike its role in recycling D-aminoacyl-tRNAs ([@bib50]). The work has brought to the fore the evolutionary selection pressure that the chiral proofreading enzyme has exerted on bacterial tRNA^Gly^ to retain U73. In the primordial scenario, U73 could have been the only factor that ensured utilization of glycine for protein synthesis by precluding the unwarranted activity of DTD-like factor. Our findings have also revealed the co-evolution of eukaryotic DTD via switching of N73 specificity as this selection pressure was released through unknown mechanisms during the 1.5 billion years of evolutionary transition from bacteria to eukaryotes. The study has therefore brought to limelight the deviations that occur in the usage of discriminator base---rare choices of pyrimidine instead of purine---in tRNAs across all life forms, and the need to probe the physiological necessity to deviate from it ([Figures 1c](#fig1){ref-type="fig"} and [4d](#fig4){ref-type="fig"}). Considering the possibility that the early tRNAs operated using an acceptor stem--based 'second genetic code' or with mini-helices ([@bib7]; [@bib46]), the choice of discriminator base must have played a crucial role during the early evolution of the translational apparatus.

Materials and methods {#s4}
=====================

Cloning, expression and purification {#s4-1}
------------------------------------

The genes encoding *E. coli* DTD and *Thermus thermophilus* EF-Tu, and cDNA encoding *M. musculus* (residues 1--147) were cloned (with C-terminal 6X His-tag), expressed and purified as mentioned in [@bib2] and [@bib27]. Briefly the proteins were overexpressed in *E. coli* BL21(DE3) by growing the culture to 0.6 OD~600~ at 37°C, followed by induction using 0.5 mM IPTG for 12 hr at 18°C. The cells were harvested by centrifugation at 8000 rpm for 10 min. The harvested cells were lysed and the supernatant was subjected to two-step purification involving affinity-based chromatography followed by size exclusion chromatography (SEC). Affinity purification was done using Ni-NTA column in a solution containing 250 mM NaCl and 100 mM Tris pH 8.0. Imidazole gradient from 10 mM to 500 mM was used to elute the bound protein. Affinity-purified protein was further subjected to SEC to achieve improved purity and homogeneity in a buffer containing 200 mM NaCl and 100 mM Tris pH 7.5. These purified proteins were quantified and stored at −30°C in a buffer containing 50% glycerol. Same procedure was followed for all the proteins except MmDTD which was expressed in *E. coli* BL21-CodonPlus(DE3)-RIL strain.

Biochemical assays {#s4-2}
------------------

tRNAs were generated by *in vitro* transcription of genes encoding *E. coli* tRNA^Gly/Ala^ and *M. musculus* tRNA^Gly/Ala^ using MEGAshortscript T7 Transcription Kit (Thermo Fisher Scientific, USA). Various mutants of tRNA^Gly^ were generated using QuickChange XL Site-Directed Mutagenesis Kit (Agilent Technologies, USA). The *in vitro* transcribed tRNAs were 3′ end labelled using CCA-adding enzyme ([@bib29]). Glycylation of tRNA^Gly^ and mutants of tRNA^Gly^ (U73A, U73G, U73C, U73A/C70U) were done using *T. thermophilus* glycyl-tRNA synthetase, while tRNA^Ala^ was glycylated using *E. coli* AlaRS as explained in [@bib38]. Deacylation assays and EF-Tu protection experiments were performed according to the protocol explained in [@bib38]. Briefly, deacylation was carried out, in 20 mM Tris pH 7.2, 5 mM dithiothreitol (DTT), 20 mM MgCl~2~, 0.2 µM of substrate (aminoacylated tRNA), at 30°C with variable concentrations of DTD. EF-Tu activation is done in buffer containing 50 mM HEPES pH 7.2, 20 mM MgCl~2~, 250 mM NH~4~Cl, 5 mM DTT, 3 mM phosphoenol pyruvate and pyruvate kinase as explained in [@bib41]. EF-Tu protection assays were performed in a buffer containing 2 µM *T. thermophilus* EF-Tu's (of which usually 10--15% is activated ([@bib13]; [@bib44]), hence EF-Tu effective concentration is 200--300 nM), 100 mM HEPES pH 7.2, 2.5 mM DTT and variable concentrations of DTD (determined by Bradford assay). A range of enzyme (DTD) concentrations were tested, and, in general, the concentration that gave a gradual deacylation curve was selected for comparison and reporting. GraphPad Prism software was used for curve fitting and every data point represents mean of at least three independent readings. Error bars indicate one standard deviation from the mean.

Northern blotting {#s4-3}
-----------------

Northern blotting was performed according to the protocol given in [@bib54]. Briefly, 1% of overnight-grown 2 mL primary culture (*E. coli* MG1655Δ*dtd*::Kan cells overexpressing PfDTD wild-type or A112F mutant) was used to initiate 10 mL secondary culture and grown at 37°C till OD~600~ reached 0.6, following which the culture was induced with 0.1 mM IPTG and allowed to grow at 37°C for additional 5--6 hr. The culture was harvested and total RNA was extracted using the general acidic phenol--based method; all the steps were carried out on ice or at 4°C. This was followed by running the total RNA (0.15--0.25 *A*~260~ unit) on 6.5% acid--urea PAGE at 4°C for 20--24 hr. The RNA from the gel was electroblotted on Hybond^+^ membrane at 15 V, 3 A for 25 min, and tRNA^Gly^~GCC~ was hybridized with \[^32^P\]-labeled probe (probe sequence: 5′-AGCGGGAAACGAGACTCGAACTCGC-3′). The probe was labeled using \[γ-^32^P\]-ATP in a general polynucleotide kinase reaction. The signal from the probe was recorded overnight on image plate and quantified using phosphoimager.

Strain construction {#s4-4}
-------------------

Wild-type GFP (pBAD18-sfGFP) was a kind gift from Dr. Manjula Reddy's laboratory. Non-fluorescing mutant of GFP was generated by introducing a glycine-to-alanine point mutation at the 67th position (sfGFP-G67A). Editing-defective *alaS E. coli* MG1655 strain (i.e. Δ*alaS*) was created by knocking out the genomic copy of *alaS* and complementing it with triple-mutant (T567F/S587W/C666F) AlaRS gene cloned in pBAD33 vector. The same strategy of making AlaRS editing-deficient was also used in Δ*dtd E. coli* MG1655 strain, thereby creating *dtd*-null strain in AlaRS editing-defective background (i.e. Δ*dtd*Δ*alaS*) ([@bib38]). sfGFP and sfGFP-G67A, cloned in pBAD18 vector, were under the control of an arabinose-inducible promoter.

Microscopy {#s4-5}
----------

To monitor GFP fluorescence in Δ*alaS* (Δ*alaS*/p~ara~::*alaS*-T567F, S587W, C666F) and Δ*dtd*Δ*alaS* (Δ*dtd*, Δ*alaS*/p~ara~::*alaS*-T567F, S587W, C666F) strains were co-expressed with mutant GFP (pBAD18-GFP G67A). Primary cultures were grown at 37°C in LB medium containing 0.002% L-arabinose, 100 mg ml^−1^ ampicillin and 20 μg ml^−1^ chloramphenicol. 3% inoculum was used to initiate 5 mL secondary culture in 1X minimal salts with 0.2% maltose as carbon source and 0.002% L-arabinose; the secondary culture was supplemented with 0, 3, 10 or 60 mM glycine. Cells were immobilized on a thin agarose (1.5%) slide and visualized under a Zeiss Axioimager microscope in DIC (Nomarski optics) and EGFP (Fluorescence) mode. All the experiments were done in biological triplicates.

Bioinformatic analysis {#s4-6}
----------------------

The prokaryotic tRNA sequences were analyzed using the tRNADB-CE ([@bib1]). The numbers were derived using advance pattern search option, wherein anticodon sequence and the ^73^NCCA^76^ were used as the search parameters and the rest were set to default. While eukaryotic tRNAs were retrieved from GtRNAdb (<http://gtrnadb.ucsc.edu/>), only those sequences whose tRNA-scan score is above 50 were considered for analysis. The consensus sequence logo was obtained by using WebLogo server (<http://weblogo.berkeley.edu/logo.cgi>).

Funding Information
===================

This paper was supported by the following grants:

-   http://dx.doi.org/10.13039/501100001409Department of Science and Technology, Ministry of Science and Technology DST-INSPIRE to Santosh Kumar Kuncha.

-   http://dx.doi.org/10.13039/501100001407Department of Biotechnology , Ministry of Science and Technology DBT-RA to Katta Suma.

-   http://dx.doi.org/10.13039/501100001407Department of Biotechnology, Ministry of Science and Technology Centre of Excellence to Rajan Sankaranarayanan.

-   http://dx.doi.org/10.13039/501100001843Science and Engineering Research Board J. C. Bose Fellowship to Rajan Sankaranarayanan.

The authors thank Prof. Umesh Varshney and Ashwin G, Indian Institute of Science, Bengaluru, India for their help with northern blotting. SKK thanks DST-INSPIRE, India, and KS thanks DBT-RA Programme, India, for research fellowships. RS acknowledges funding from 12th Five Year Plan Project BSC0113 of CSIR, India, JC Bose Fellowship of SERB, India, and Centre of Excellence Project of Department of Biotechnology, India. The funding agencies had no role in study design, analysis, decision to publish or preparation of the manuscript.

Additional information {#s5}
======================

No competing interests declared.

Conceptualization, Formal analysis, Investigation, Methodology, Writing---original draft, Writing---review and editing.

Formal analysis, Investigation, Methodology, Writing---review and editing.

Formal analysis, Investigation, Methodology, Writing---review and editing.

Formal analysis, Investigation, Methodology.

Formal analysis, Investigation, Methodology, Writing---review and editing.

Investigation, Methodology.

Formal analysis, Investigation, Methodology, Writing---review and editing.

Conceptualization, Supervision, Writing---original draft, Project administration, Writing---review and editing.

Additional files {#s6}
================

10.7554/eLife.38232.012

Data availability {#s7}
-----------------

Biochemical data is available as a source data file. All other data are included in the manuscript and supporting files.

10.7554/eLife.38232.015

Decision letter

Staley

Jonathan P

Reviewing Editor

University of Chicago

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"A discriminator code-based DTD surveillance ensures faithful glycine delivery for protein biosynthesis in bacteria\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Jonathan P Staley as the Reviewing Editor and Reviewer \#2, and the evaluation has been overseen by Michael Marletta as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Michael Ibba (Reviewer \#1); Karin Musier-Forsyth (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This \"Research advance\" follows on a recent *eLife* publication from the same group showing that DTD proofreads, in addition to its broad role in deacylating D-aminoacylated tRNAs, by deacylating Gly-tRNA^Ala^. In this manuscript, the authors investigate the mechanistic basis for the 1000-fold discrimination by DTD between mischarged Gly-tRNA^Ala^ and Gly-tRNA^Gly^ in *E. coli*. Here, the authors show intriguingly that 100-fold of the specificity can be accounted for solely by the identity of the so-called discriminator base. Whereas this base is generally a purine, with adenine indicating aliphatic residues and guanine indicating polar residues, in tRNA^Gly^ this base is an exception, as a uracil. In a key experiment, the authors show that mutation of this uracil to adenine or guanine in tRNA^Gly^ renders Gly-tRNA^Gly^ sensitive to (inappropriate) deacylation. Thus, the authors have both rationalized an unusual exception to the discriminator base rules and identified a significant determinant of DTD specificity. The authors further show that in eukaryotes, where the discriminator base in tRNA^Gly^ has shifted to an adenine, the specificity of DTD has switched to prefer purine over uracil, and as a consequence, DTD only imposes a 10-fold reduction in mischarged Gly-tRNA^Ala^. Lastly, in a clever experiment, the authors demonstrate the physiological significance of DTD proofreading of Gly-tRNA^Ala^ by showing that in the absence of DTD, glycine can be mis-incorporated into a key position of GFP, conferring fluorescent functionality to the protein. In the past, DTD was thought to only act on chiral amino acids and to only recognize the amino acid component of aminoacyl-tRNA. Here, the authors show physiological relevance in achiral proofreading for protein synthesis and define a key and intriguing element in the tRNA body that impacts DTD specificity. This work will be of wide interest to those interested in translation and/or mechanisms of specificity and builds very interestingly on the original Crothers Discriminator Hypothesis.

Essential revisions:

1\) In subsection "N73 and G3•U70 have an additive effect on DTD's activity", the authors assert that they have established DTD only interacts with the acceptor stem, a conclusion that would require additional biophysical data. What has been shown is that the functionally important interactions are confined to the acceptor stem.

2\) The idea of \"reciprocal\" evolution is confusing and ultimately unnecessary. The study clearly shows things work differently in eukaryotes, although how is still unclear, and it would best be left at that.

3\) Many experimental details are missing in the Materials and methods section. The concentration of aminoacyl-tRNA substrates is not reported anywhere in the paper. The deacylations performed in the presence of EF-Tu do not report a concentration of EF-Tu. The use of different DTD concentrations is reported, but how were these determined? What were the conditions of the deacylation reactions?

4\) The results are qualitative and it is not clear that the quantitative results reported in Supplementary Table 1 are valid. The Km is not reported and the enzyme concentration should be significantly below the Km for this analysis to be valid. In addition, the equation used to calculate *k*~obs~ should only be applied to fit a reaction performed under single turnover conditions for valid comparisons. Was the E in significant excess over tRNA? Was the buffer background rate subtracted prior to calculating the rates?

5\) The authors state: \"... cognate depletion is observed even in the uninduced sample of wild-type DTD, suggesting leaky expression of the wild-type copy from the recombinant plasmid. These data clearly show that the toxicity caused by DTD overexpression is due to the depletion of cellular Gly-tRNA^Gly^ levels, thus warranting a strict control on endogenous levels of DTD.\" The Northern blot showed complete depletion of Gly-tRNA^Gly^ even without induction. So, shouldn\'t this leaky expression also cause cell toxicity?

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"A discriminator code-based DTD surveillance ensures faithful glycine delivery for protein biosynthesis in bacteria\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Michael Marletta (Senior Editor) and a Reviewing Editor.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

1\) Regarding essential revision \#4, because the reactions are not performed under single turnover conditions, the equation for *k*~obs~ is not valid. Consequently, the authors need to remove Supplementary Table 1.

2\) Regarding essential revision \#5, the authors have not provided a satisfactory answer. That the authors \"believe\" that with leaky expression the Gly-tRNA^Gly^ produced is just sufficient for translation is not an acceptable response to the concern; while this is a reasonable explanation for the discrepancy, the data do not support this explanation, presumably due to the insensitivity of the assay to low levels of Gly-tRNA^Gly^. The authors have two options. First, they can repeat the assay and prove that in fact with leaking expression there are low levels of Gly-tRNA^Gly^. Second, omit the premature conclusion that DTD over expression is due to depletion of this tRNA.

10.7554/eLife.38232.016

Author response

> Essential revisions:
>
> 1\) In subsection "N73 and G3•U70 have an additive effect on DTD's activity", the authors assert that they have established DTD only interacts with the acceptor stem, a conclusion that would require additional biophysical data. What has been shown is that the functionally important interactions are confined to the acceptor stem.

As correctly pointed out by the reviewer(s), we have not provided any direct evidence that DTD interacts with only the acceptor stem of tRNA. However, unlike other proteins (aaRS and EF-Tu) which interact with tRNA, DTD is smaller in size (16-18 kDa) and a simple modeling suggests that the recognition is not expected to go beyond the tRNA acceptor stem. Nevertheless, as we have no direct evidence, now the statement has been appropriately modified in the revised version of the manuscript, as suggested by the reviewer(s) and given below:

"These results also clearly establish that functionally important interactions of DTD are confined only to the acceptor stem of tRNA."

> 2\) The idea of \"reciprocal\" evolution is confusing and ultimately unnecessary. The study clearly shows things work differently in eukaryotes, although how is still unclear, and it would best be left at that.

By "reciprocal" evolution of N73 and DTD in Bacteria and Eukarya, we just wanted to underscore the fact that bacterial DTD acts more efficiently on purine at N73 when compared to pyrimidine at that position, eukaryotic DTD shows exactly the reverse phenomenon. However, since this is confusing and possibly unnecessary, we have removed it from the revised version of the manuscript, as suggested by the reviewer(s).

> 3\) Many experimental details are missing in the Materials and methods section. The concentration of aminoacyl-tRNA substrates is not reported anywhere in the paper. The deacylations performed in the presence of EF-Tu do not report a concentration of EF-Tu. The use of different DTD concentrations is reported, but how were these determined? What were the conditions of the deacylation reactions?

The instruction to authors as mentioned for 'Research Advance' suggests not to add a detailed Materials and methods and hence we left out some of the details mentioned in our previous work by Pawar et al., *eLife*, 2017. However, since the reviewer(s) deem it appropriate to incorporate some of the crucial details (such as substrate concentration) in the current manuscript as well, we have now mentioned them in the "Materials and methods" section of the revised manuscript. The enzyme concentration was determined by Bradford assay (further validated by measuring OD~280~ using NanoDrop 1,000 Spectrophotometer (Thermo Scientific)), a range of enzyme concentrations were tested, and in general, the concentration that gave a gradual deacylation curve was selected for comparison and reporting. This too has now been mentioned in the revised manuscript.

> 4\) The results are qualitative and it is not clear that the quantitative results reported in Supplementary Table 1 are valid. The Km is not reported and the enzyme concentration should be significantly below the Km for this analysis to be valid. In addition, the equation used to calculate k~obs~ should only be applied to fit a reaction performed under single turnover conditions for valid comparisons. Was the E in significant excess over tRNA? Was the buffer background rate subtracted prior to calculating the rates?

We agree with the reviewer(s) that the results are qualitative. And therefore, the values given are purely indicative. Since higher concentration of DTD leads to rapid deacylation of substrate we had to use lower concentration of enzyme to get gradual deacylation curves. Moreover, the *k*~obs~ in our equation simply signifies the first-order decay constant, as the curves in the graphs themselves suggest that deacylations at the given enzyme concentrations follow first-order exponential decay. That is the reason for us to keep this table in the supplementary information. The buffer deacylation rate (now mentioned in supplementary table 1) was subtracted to obtain the effective rate of enzymatic deacylation, and this has now been explicitly mentioned in the manuscript. However, if the reviewer(s) still feels that the results need not be quantified in this manner we can remove the Supplementary Table 1.

> 5\) The authors state: \"... cognate depletion is observed even in the uninduced sample of wild-type DTD, suggesting leaky expression of the wild-type copy from the recombinant plasmid. These data clearly show that the toxicity caused by DTD overexpression is due to the depletion of cellular Gly-tRNA^Gly^ levels, thus warranting a strict control on endogenous levels of DTD.\" The Northern blot showed complete depletion of Gly-tRNA^Gly^ even without induction. So, shouldn\'t this leaky expression also cause cell toxicity?

Our northern blot data do suggest a leaky expression of DTD as Gly-tRNA^Gly^ levels are depleted even in the uninduced condition. However, in our previous study (Routh et al., 2016), we could see toxicity only upon induction. We believe that the level of DTD due to leaky expression does not allow any accumulation of Gly-tRNA^Gly^ in the cell (hence, Gly-tRNA^Gly^ band is not visible in the blot), but the Gly-tRNA^Gly^ produced is just sufficient for translation to continue and prevent toxicity. However, upon induction, this delicate balance is disturbed causing toxicity due to enhanced depletion of Gly-tRNA^Gly^. This data is further strengthened by the fact that in the case of DTD inactive mutant A112F (Adenine binding pocket mutant) the Gly-tRNA^Gly^ levels are unperturbed.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:
>
> 1\) Regarding essential revision \#4, because the reactions are not performed under single turnover conditions, the equation for k~obs~ is not valid. Consequently, the authors need to remove Supplementary Table 1.

As suggested by you, Supplementary Table 1 has now been removed from the revised manuscript as well as the relevant information from the Materials and methods.

> 2\) Regarding essential revision \#5, the authors have not provided a satisfactory answer. That the authors \"believe\" that with leaky expression the Gly-tRNA^Gly^ produced is just sufficient for translation is not an acceptable response to the concern; while this is a reasonable explanation for the discrepancy, the data do not support this explanation, presumably due to the insensitivity of the assay to low levels of Gly-tRNA^Gly^. The authors have two options. First, they can repeat the assay and prove that in fact with leaking expression there are low levels of Gly-tRNA^Gly^. Second, omit the premature conclusion that DTD over expression is due to depletion of this tRNA.

We agree that the discrepancy between the uninduced and induced WT DTD in the northern blotting is probably due to the sensitivity of the experiment. Small amounts Gly-tRNA^Gly^ remaining in the uninduced condition but undetectable in our assay seems to be sufficient for translation to go on without causing cellular toxicity. Hence, the conclusion has now been modified as following:

"These data are suggestive that the toxicity caused by DTD overexpression is linked to the depletion of cellular Gly-tRNA^Gly^ levels".

[^1]: ^\*^These authors contributed equally to this work.

[^2]: These authors contributed equally to this work.
